Format

Send to

Choose Destination
Med Sci (Paris). 2019 Dec;35(12):1066-1071. doi: 10.1051/medsci/2019207. Epub 2020 Jan 6.

[Antibodies, tools of choice for fluorescence-guided surgery].

[Article in French; Abstract available in French from the publisher]

Author information

1
IRCM, Institut de Recherche en Cancérologie de Montpellier, Inserm U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, F-34298, France.
2
Institut régional du Cancer de Montpellier, ICM, Montpellier, F-34298, France.
3
SurgiMAb, 10 Parc Club du Millénaire, 1025 avenue Henri Becquerel, 34000 Montpellier, France.

Abstract

in English, French

Fluorescence-guided surgery has been developing in clinics for several years. While the use of non-targeted dyes may be useful in certain diseases, specific contrast agents are essential in oncology. As shown in the latest clinical studies, monoclonal antibodies have all the characteristics to play a major role in this field of medical imaging, provided the antigenic target is relevant.

PMID:
31903919
DOI:
10.1051/medsci/2019207

Supplemental Content

Full text links

Icon for EDP Sciences
Loading ...
Support Center